Deaths lead to review of new-generation OCPs
The European Medicines Agency (EMA) said France made the request and it was introducing initiatives to reduce its use of new-generation pills in favour of second-generation oral contraceptives.
A spokesperson for the TGA said it had recently reviewed a number of fourth-generation contraceptives and “is completing the evaluation of that information before determining whether any further updates are required”.
It said it would also review the reasons behind France’s request for the review of third-generation contraceptives.
Following reports in French newspaper Le Figaro of adverse events